Pharmaceutical Industry Today

Clinical Trial Imaging Market Set for Substantial Gains, Driven by Digitalization and Advanced Data Management

The global Clinical Trial Imaging Market is projected to grow from US$1.61 billion in 2022 to US$2.48 billion by 2028, registering a CAGR of 7.6%, according to The Insight Partners. Growth is fueled by increasing clinical research activity, the rise of specialized imaging CROs, higher pharmaceutical R&D spending, and the integration of advanced imaging endpoints such as CT, MRI, and PET in trials. Digitalization and outsourcing trends are reshaping the market, with platforms like TCS ADD Connected Clinical Trials advancing decentralized trial capabilities.
Published 14 October 2025

New York, US – October 14, 2025- According to a new report published by The Insight Partners, titled “Clinical Trial Imaging Market Size, Share, Analysis and Forecast,” the worldwide market for clinical trial imaging is poised for substantial growth. The report projects that the integration of sophisticated imaging endpoints is driving the market, as is the increasing demand for robust data management systems and the strategic outsourcing of services.  The market size is expected to reach US$2,480.32 million by 2028, up from US$1,610.70 million in 2022, recording a CAGR of 7.6% from 2023 to 2028.

Digitalization and Outsourcing Propel Market Momentum

The clinical trial imaging market is experiencing significant growth driven by key factors, including:

  • Escalating Research Volume: The continuous rise in the number of new clinical studies registered globally, especially those focused on complex therapeutic areas, necessitates the use of standardized and high-quality imaging procedures.
  • Specialization of Imaging CROs: Dedicated Contract Research Organizations (iCROs) are increasingly in demand to provide specialized expertise in imaging protocols, site qualification, and standardized image acquisition, streamlining the trial process for sponsors.
  • Intensified Pharmaceutical Funding: Major pharmaceutical and biopharmaceutical corporations are increasing their R&D expenditures, which include significant investments in imaging technologies to serve as objective, quantifiable measures of drug response.
  • Integration of Advanced Imaging Endpoints: The growing preference for non-invasive, quantifiable measurements in multicenter trials has led to the widespread incorporation of various imaging modalities (CT, MRI, PET, etc.) as primary or secondary trial endpoints.

Get a sample PDF of Clinical Trial Imaging Market- https://www.theinsightpartners.com/sample/TIPHE100001201

Recent News and Developments

The industry has witnessed a surge in innovation and strategic initiatives aimed at enhancing efficiency and leveraging technology to drive growth. For example, in a significant step toward digitizing clinical processes, Tata Consultancy Services (TCS) was recognized with the India Pharma Award 2022 for its TCS ADD Connected Clinical Trials platform. This innovation supports the move toward decentralized trials. This highlights the focus on platform-based solutions for managing complex, global imaging data.

Key Collaborations and Major Players

Strategic initiatives focused on improving workflow efficiency and data integrity are defining the market landscape. For example, the development and integration of Clinical Trial Imaging Management Systems (CTIMS) are crucial for ensuring regulatory compliance and seamless data management across global trials.

Key Players operating in the Clinical Trial Imaging Market include:

  • eResearch Technology Inc
  • Calyx Inc
  • ICON PLC
  • VIDA Diagnostics Inc
  • WCG Clinical Inc
  • BioTelemetry Inc
  • Medical Metrics Inc
  • Medpace Holdings Inc
  • Radiant Sage LLC

Access Clinical Trial Imaging Market Report 2031https://www.theinsightpartners.com/buy/TIPHE100001201

Future Outlook

The future of the Clinical Trial Imaging Market looks promising, with continued growth expected due to the ongoing shift toward personalized medicine, which requires precise diagnostic and monitoring tools. The continuous development of advanced imaging software and the increasing integration of AI for read analysis are also expected to be key drivers for product innovation and efficiency improvements.

Market Analysis from The Insight Partners

"The critical reliance on objective imaging data and the sheer complexity of managing multi-site imaging have made specialized imaging solutions an absolute necessity," stated The Insight Partners. "Innovations in decentralized trials and imaging management systems are not just driving market growth, but are also fundamentally changing how clinical data is acquired and analyzed, ultimately accelerating drug development."

Related Reports:

Clinical Trials Market Growth and Analysis by 2031

Medical Imaging Market Size, Share, and Analysis by 2031

Diagnostic Imaging Market Growth, Trends, and Analysis by 2031

Medical Image Management Market Growth, Size, Share, Trends, Key Players Analysis, and Forecast till 2031

Molecular Imaging Market Dynamics, Business Growth, Trends, and Opportunities 2031

About The Insight Partners

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media, and Telecommunications, as well as chemicals and Materials.

Contact Us

Email: sales@theinsightpartners.com

Website: www.theinsightpartners.com

Phone: +1-646-491-9876

Also Available in : KoreanGermanJapaneseFrenchChineseItalian

Other Industry News

Ready to start publishing

Sign Up today!